Praxis Precision Medicines: Deutsche Bank raises target price to $483 from $475
PRAX•Deutsche Bank raised its target price for Praxis Precision Medicines to $483 from $475.
Related News

Huadi International holds extraordinary general meeting of shareholders
HUDI•

Chord Energy Corporation: Scotiabank raises target price to $197 from $192
CHRD•

Scotiabank raises Gulfport Energy Corporation target price to $221 from $217
GPOR•

Cardiff Oncology gets FDA fast track designation for onvansertib combination in first-line RAS-mutated colorectal cancer
CRDF•

Bioxytran launches first nutraceutical products for blood sugar, immune support
BIXT•